ArticleCancer chemotherapy and pharmacology2020

Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors.

Akihito Kawazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.